Literature DB >> 16875723

Willingness to receive an HIV vaccine among incarcerated persons.

Michelle Lally1, Melissa Gaitanis, Snigdha Vallabhaneni, Steven Reinert, Kenneth Mayer, Gregory Zimet, Josiah Rich.   

Abstract

BACKGROUND: Once an HIV vaccine becomes available, high-risk adults will be a target population for vaccination, and HIV vaccination programs for inmates may be a public health priority. Nothing is known about U.S. inmates' willingness to accept an anticipated HIV vaccine while incarcerated. The goal of this study was to examine inmates' attitudes toward a potential HIV vaccine.
METHODS: In 2002, we interviewed 153 male and female inmates at the Rhode Island Department of Corrections (RIDOC) using a voluntary, anonymous survey.
RESULTS: Ninety-three percent of inmates indicated they would be willing to receive a hypothetical HIV vaccine while incarcerated. Although 88% of inmates self-reported at least one HIV risk factor, only 20% perceived themselves to be at risk for HIV.
CONCLUSION: Once an HIV vaccine becomes available, HIV vaccination programs in the correctional setting need to become a public health priority. These would be well received by inmates in Rhode Island.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16875723      PMCID: PMC3249390          DOI: 10.1016/j.ypmed.2006.06.012

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  20 in total

1.  Intraprison HIV transmission: an assessment of whether it occurs, how it occurs, and who is at risk.

Authors:  Christopher P Krebs; Melanie Simmons
Journal:  AIDS Educ Prev       Date:  2002-10

2.  The importance of routine HIV testing in the incarcerated population: the Rhode Island experience.

Authors:  Amar A Desai; E Timothy Latta; Anne Spaulding; Josiah D Rich; Timothy P Flanigan
Journal:  AIDS Educ Prev       Date:  2002-10

3.  Hepatitis B vaccination of incarcerated women: a pilot program.

Authors:  Jennifer Clarke; Beth Schwartzapfel; Jennifer Pomposelli; Scott Allen; Anne Spaulding; Josiah D Rich
Journal:  J Health Care Poor Underserved       Date:  2003-08

4.  Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons.

Authors:  Grace E Macalino; David Vlahov; Stephanie Sanford-Colby; Sarju Patel; Keith Sabin; Christopher Salas; Josiah D Rich
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

Review 5.  Current progress in the development of HIV vaccines.

Authors:  Paul Spearman
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 6.  Correctional health care: a public health opportunity.

Authors:  J B Glaser; R B Greifinger
Journal:  Ann Intern Med       Date:  1993-01-15       Impact factor: 25.391

7.  Posttrial HIV vaccine adoption: concerns, motivators, and intentions among persons at risk for HIV.

Authors:  Peter A Newman; Naihua Duan; Ellen T Rudy; Kathleen J Roberts; Dallas Swendeman
Journal:  J Acquir Immune Defic Syndr       Date:  2004-11-01       Impact factor: 3.731

8.  Factors associated with the acceptance of an AIDS vaccine: an exploratory study.

Authors:  Richard A Crosby; David R Holtgrave; Lawrence Bryant; Paula M Frew
Journal:  Prev Med       Date:  2004-10       Impact factor: 4.018

9.  Prisoners' attitudes toward Hepatitis B vaccination.

Authors:  Snigdha Vallabhaneni; Grace E Macalino; Steven E Reinert; Beth Schwartzapfel; Francis A Wolf; Josiah D Rich
Journal:  Prev Med       Date:  2004-06       Impact factor: 4.018

10.  Correlates of negative intent to receive an AIDS vaccine: an exploratory study.

Authors:  Richard A Crosby; David R Holtgrave; Lawrence Bryant; Paula M Frew
Journal:  Int J STD AIDS       Date:  2004-08       Impact factor: 1.359

View more
  3 in total

1.  Willingness to participate in trials and to be vaccinated with new tuberculosis vaccines in HIV-infected adults.

Authors:  T Kufa; V Chihota; S Charalambous; S Verver; G Churchyard
Journal:  Public Health Action       Date:  2013-03-21

2.  Young at risk-people in Maputo City, Mozambique, present a high willingness to participate in HIV trials: Results from an HIV vaccine preparedness cohort study.

Authors:  Igor P U Capitine; Ivalda B Macicame; Artur M Uanela; Nilesh B Bhatt; Adam Yates; Mark Milazzo; Chiaka Nwoga; Trevor A Crowell; Nelson L Michael; Merlin L Robb; Ilesh V Jani; Arne Kroidl; Christina S Polyak; Caroline De Schacht
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

3.  HIV vaccine acceptability among high-risk drug users in Appalachia: a cross-sectional study.

Authors:  April M Young; Ralph J DiClemente; Daniel S Halgin; Claire E Sterk; Jennifer R Havens
Journal:  BMC Public Health       Date:  2014-05-30       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.